Trading Signals: CEMI Stock Price Prediction and Forecast (Wed. Nov. 26, 2003 - Wed. Jul. 21, 2021)(Chembio Diagnostics Inc)
| CEMI latest price $5.3900 (-0.19%) ($5.2700 - $5.5400) on Fri. Oct. 25, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 43 | Latest Price | $5.3900(-0.19%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CEMI advances 0.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CEMI advance at 0% a week (0% probability) UNG(21%) IGOV(7%) USO(7%) XAR(7%) XRT(6%) | Factors Impacting CEMI price | CEMI will decline at least -1.665% in a week (0% probabilities). URA(-10%) IPO(-7%) JNK(-6%) HYG(-6%) BLOK(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | 0 () | Intraday Trend | 0.2% | | | |
|
Resistance Level | $5.58 | 5 Day Moving Average | $5.54(-2.71%) | 10 Day Moving Average | $5.52(-2.36%) | 20 Day Moving Average | $5.58(-3.41%) | To recent high | -25.7% | To recent low | 6.9% | Market Cap | $109m | | | | Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY. |